TOP TIERMARKET NEWSWIRE
SEC Form 4 history

RECURSION PHARMACEUT A (RXRX) insider trades

RECURSION PHARMACEUT A (RXRX) insider trading activity (SEC Form 4). Over the trailing 90 days, RXRX insiders filed 0 purchases totalling $0 and 5 sales totalling $701K — net SELLING of $701K. Most recent filing: Nov 4, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$701K
Net (90d)
-$701K
net selling
Most recent
Nov 4, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 4, 2026Borgeson BlakeDirS Sale—$3.88$155Kfiling
Oct 7, 2026Hershberg RobertDirS SaleOE—$5.00$125Kfiling
Oct 7, 2026Borgeson BlakeDirS Sale—$4.84$242Kfiling
Sep 10, 2026Khan NajatCEO, PresS Sale—$3.52$79Kfiling
Sep 2, 2026Borgeson BlakeDirS Sale—$3.34$100Kfiling
Aug 6, 2026Borgeson BlakeDirS Sale—$3.25$98Kfiling
Jul 9, 2026Borgeson BlakeDirS Sale—$3.96$159Kfiling
Jun 22, 2026Bumpus NamandjeDirS Sale—$3.18$13Kfiling
Jun 5, 2026Khan NajatCEO, PresS Sale—$3.58$84Kfiling
Jun 5, 2026Gibson ChristopherDirS SaleOE—$3.62$145Kfiling
Jun 4, 2026Bumpus NamandjeDirS Sale—$3.54$16Kfiling
Jun 4, 2026Borgeson BlakeDirS Sale—$3.68$110Kfiling
May 27, 2026Gibson ChristopherDirS SaleOE—$3.08$123Kfiling